Clinical vs. laboratory identification of drugs of abuse in patients admitted for acute poisoning

Clinical Toxicology

Volumn 44, Issue 2, 2006, Pages 127-134

  Bjornaas, M A ^a,b   Hovda, K E ^a   Mikalsen, H ^c   Andrew, E ^c   Rudberg, N ^a   Ekeberg, O ^a   Jacobsen, D ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c Poisons Information   (Norway)

Author keywords

Analysis; Diagnosis; Drug abuse; Poisoning

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXYBUTYRIC ACID; ALCOHOL; AMPHETAMINE; BENZODIAZEPINE; CANNABIS; COCAINE; OPIATE; STREET DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANAMNESIS; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG ABUSE; DRUG ABUSE PATTERN; DRUG INTOXICATION; FEMALE; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; KAPPA STATISTICS; LABORATORY DIAGNOSIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SEX RATIO; URINALYSIS; ACUTE DISEASE; ADDICTION; AGE; BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIAGNOSIS, MEASUREMENT AND ANALYSIS; INTOXICATION; METHODOLOGY; MIDDLE AGED; SEX DIFFERENCE; SUBSTANCE ABUSE; URINE;

CANNABIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MALE; MIDDLE AGED; POISONING; SEX FACTORS; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 33645997341     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650500514384     Document Type: Article

References (23)

1. Jones AL, Volans G. Management of self poisoning. BMJ 1999; 319(7222):1414-1417.
2. Jacobsen D, Frederichsen PS, Knutsen KM, Sorum Y, Talseth T, Odegaard OR. A prospective study of 1212 cases of acute poisoning: general epidemiology. Hum Toxicol 1984; 3(2):93-106.
3. Buajordet I, Naess AC, Jacobsen D, Brors O. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Eur J Emerg Med 2004; 11(1):19-23.
4. Hedetoft C, Christensen HR. Amphetamine, ecstasy and cocaine. Clinical aspects of acute poisoning. Ugeskr Laeger 1999; 161(50):6907-6911.
5. Miro O, Nogue S, Espinosa G, To-Figueras J, Sanchez M. Trends in illicit drug emergencies: the emerging role of gamma-hydroxybutyrate. J Toxicol Clin Toxicol 2002; 40(2):129-135.
6. Engelsen J, Christensen HR. Gamma-hydroxybutyrate - an endogenous substance and a new central nervous system stimulant. Clinical aspects of acute poisoning. Ugeskr Laeger 1999; 161(50):6903-6907.
7. Degenhardt L, Darke S, Dillon P. The prevalence and correlates of gamma-hydroxybutyrate (GHB) overdose among Australian users. Addiction 2003; 98(2):199-204.
8. Brett AS. Implications of discordance between clinical impression and toxicology analysis in drug overdose. Arch Intern Med 1988; 148(2):437-441.
9. Wright N. An assessment of the unreliability of the history given by self-poisoned patients. Clin Toxicol 1980; 16(3):381-384.
10. Taylor RL, Cohan SL, White JD. Comprehensive toxicology screening in the emergency department: an aid to clinical diagnosis. Am J Emerg Med 1985; 3(6):507-511.
11. Dawson AH, Whyte IM. Therapeutic drug monitoring in drug overdose. Br J Clin Pharmacol 2001; 52(Suppl.):197S-102S.
12. Montague RE, Grace RF, Lewis JH, Shenfield GM. Urine drug screens in overdose patients do not contribute to immediate clinical management. Ther Drug Monit 2001; 23(1):47-50.
13. Pohjola-Sintonen S, Kivisto KT, Vuori E, Lapatto-Reiniluoto O, Tiula E, Neuvonen PJ. Identification of drugs ingested in acute poisoning: correlation of patient history with drug analyses. Ther Drug Monit 2000; 22(6):749-752.
14. Ray JE, Reilly DK, Day RO. Drugs involved in self-poisoning: verification by toxicological analysis. Med J Aust 1986; 144(9):455-457.
15. Skelton H, Dann LM, Ong RT, Hamilton T, Ilett KF. Drug screening of patients who deliberately harm themselves admitted to the emergency department. Ther Drug Monit 1998; 20(1):98-103.
16. Rygnestad T, Berg KJ. Evaluation of benefits of drug analysis in the routine clinical management of acute self poisoning. J Toxicol Clin Toxicol 1984; 22(1):51-61.
17. Helliwell M, Hampel G, Sinclair E, Huggett A, Flanagan RJ. Value of emergency toxicological investigations in differential diagnosis of coma. Br Med J 1979; 2(6194):819-821.
18. Rockett IR, Putnam SL, Jia H, Smith GS. Assessing substance abuse treatment need: a statewide hospital emergency department study. Ann Emerg Med 2003; 41(6):802-813.
19. Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977; 33(2):363-374.
20. Ellis GM Jr, Mann MA, Judson BA, Schramm NT, Tashchian A. Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clin Pharmacol Ther 1985; 38(5):572-578.
21. Morland J, Bugge A, Skuterud B, Steen A, Wethe GH, Kjeldsen T. Can-nabinoids in blood and urine after passive inhalation of Cannabis smoke. J Forensic Sci 1985; 30(4):997-1002.
22. Lu NT, Taylor BG. Drug screening and confirmation by GC-MS: Comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories. Forensic Sci Int 2005.
23. Rygnestad T, Aarstad K, Gustafsson K, Jenssen U. The clinical value of drug analyses in deliberate self-poisoning. Hum Exp Toxicol 1990; 9(4):221-230.